L

Ligand Pharmaceuticals
D

LGND

109.500
USD
0.44
(0.40%)
مغلق
حجم التداول
4,301
الربح لكل سهم
6
العائد الربحي
-
P/E
-498
حجم السوق
2,111,265,339
أصول ذات صلة
AMGN
AMGN
-2.15
(-0.76%)
281.20 USD
E
EXEL
0.700
(1.80%)
39.600 USD
INCY
INCY
0.500
(0.81%)
62.500 USD
LLY
LLY
10.33
(1.27%)
823.96 USD
MRK
MRK
-0.090
(-0.11%)
83.160 USD
N
NKTR
-0.02630
(-3.38%)
0.75210 USD
REGN
REGN
15.98
(2.71%)
606.12 USD
المزيد
الأخبار المقالات

العنوان: Ligand Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license andmilestone payments, and sale of its trademarked Captisol material.